-Bloomberg
RBC Capital Maintains Outperform on Verisk Analytics, Raises Price Target to $235
RBC Capital analyst Ashish Sabadra maintains Verisk Analytics (NASDAQ:VRSK) with a Outperform and raises the price target from $203 to $235.
Fed’s Kaplan Says Sees Jobless Rate Drifting Down To 4.5% By Year-End
-Bloomberg
Related Posts
‘Meta Platforms Announcing Pytorch Foundation To Accelerate Progress In AI Research’ – FB
https://about.fb.com/news/2022/09/pytorch-foundation-to-accelerate-progress-in-ai-research/
Since 2016, when we partnered with the AI community to create the PyTorch framework for AI research, open
Allogene Reports Receives FDA Orphan Drug Designation For ALLO-715 For Treatment Of Multiple Myeloma
ODD Follows RMAT Designation Granted to ALLO-715 by the U.S. Food and Drug Administration in Multiple Myeloma Patients
Phase 1 Data from the ALLO-715 UNIVERSAL Trial Demonstrated for the First Time that an Allogeneic
Memic Going Public Via SPAC: What Investors Should Know About This Medical Device Company
A SPAC led by the founder of Memic Innovative Surgery and several experienced medical device company executives has announced its merger partner.